Different effects of phencyclidine and methamphetamine on firing activity of medial prefrontal cortex neurons in freely moving rats

Brain Research

Volumn 962, Issue 1-2, 2003, Pages 226-231

  Jodo, Eiichi ^a   Suzuki, Yoshiaki ^a   Takeuchi, Satoshi ^a   Niwa, Shin Ichi ^a   Kayama, Yukihiko ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Dissociative anesthetic; Electrophysiology; Hyperlocomotion; Psychomotor stimulant; Unit recording

Indexed keywords

METHAMPHETAMINE; PHENCYCLIDINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; DRUG EFFECT; ELECTROPHYSIOLOGY; FRONTAL CORTEX; HYPERACTIVITY; LOCOMOTION; MALE; NERVE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; EVOKED POTENTIALS; INJECTIONS, INTRAPERITONEAL; MALE; METHAMPHETAMINE; MICROELECTRODES; NEURONS; PHENCYCLIDINE; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME;

EID: 0037423009     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)03967-7     Document Type: Article

References (29)

1. Angrist B., Sathananthan G., Wilk S. Amphetamine psychosis: behavioral and biochemical aspects. J. Psychiatr. Res. 11:1974;13-23.
2. Arnold H.M., Fadel J., Sarter M., Bruno J.P. Amphetamine-stimulated cortical acetylcholine release: role of the basal forebrain. Brain Res. 894:2001;74-87.
3. Ashby C.R.J., Edwards E., Wang R.Y. Electrophysiological evidence for a functional interaction between 5-HT1A and 5-HT2A receptors in the rat medial prefrontal cortex: an iontophoretic study. Synapse. 17:1994;173-181.
4. Bakker C.B., Amini F.B. Observations on the psychotomimetic effects of Sernyl. Compr. Psychiatry. 2:1961;269-280.
5. Castellani S., Adams P.M. Effects of dopaminergic drugs on phencyclidine-induced behavior in the rat. Neuropharmacology. 20:1981;371-374.
6. Creese I., Iversen S.D. The pharmachological and anatomical substrates of the amphetamine response in the rat. Brain Res. 83:1975;419-436.
7. Greene R. Circuit analysis of NMDAR hypofunction in the hippocampus, in vitro, and psychosis of schizophrenia. Hippocampus. 11:2001;569-577.
8. Grunze H.C., Rainie D.G., Hasselmo M.E., et al. NMDA-dependent modulation of CA1 local circuit inhibition. J. Neurosci. 16:1996;2034-2043. [Computer file].
9. Gulledge A.T., Jaffe D.B. Dopamine decreases the excitability of layer V pyramidal cells in the rat prefrontal cortex. J. Neurosci. 18:1998;9139-9151.
10. Haracz J.L., Tschanz J.T., Greenberg J., Rebec G.V. Amphetamine-induced excitation predominate in single neostriatal neurons showing motor-related activity. Brain Res. 489:1989;365-368.
11. Haracz J.L., Tschanz J.T., Wang Z., White I.M., Rebec G.V. Striatal single-unit responses to amphetamine and neuroleptics in freely moving rats. Neurosci. Biobehav. Rev. 17:1993;1-12.
12. Hedou G., Homberg J., Martin S., Wirth K., Felden J., Heidbreder C.A. Effect of amphetamine on extracellular acetylcholine and monoamine levels in subterritories of the rat medial prefrontal cortex. Eur. J. Pharmacol. 390:2000;127-136.
13. Ingvar D.H. Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia. Acta Psychiatrica Scand. 50:1974;425-462.
14. Javitt D.C., Zukkin S.R. Recent Advances in the Phencyclidine Model of Schizophrenia. Am. J. Psychiat. 148:1991;1301-1308.
15. Jay T.M., Glowinski J., Thierry A.M. Inhibition of hippocampo-prefrontal cortex excitatory responses by the mesocortical DA system. Neuroreport. 6:1995;1845-1848.
16. Jay T.M., Witter M.P. Distribution of hippocampal CA1 and subicular efferents in the prefrontal cortex of the rat studied by means of anterograde transport of Phaseolus vulgaris-Leucoagglutinin. J. Comp. Neurol. 313:1991;574-586.
17. Jentsch J.D., Dazzi L., Chhatwal J.P., Verrico C.D., Roth R.H. Reduced prefrontal cortical dopamine, but not acetylcholine, release in vivo after repeated, intermittent phencyclidine administration to rats. Neurosci. Lett. 258:1998;175-178.
18. Johnstone M., Evans V., Baigel S. Sernyl (C1-395) in clinical anesthesia. Br. J. Anaesth. 31:1958;433-439.
19. Karler R., Calder L.D., Thai D.K., Bedingfield J.B. The role of dopamine and GABA in the frontal cortex of mice in modulating a motor-stimulant effect of amphetamine and cocaine. Pharmacol. Biochem. Behav. 60:1998;237-244.
20. Luby E.D., Cohen B.D., Rosenbaum G., Gottlieb J.S., Kelley R. Study of a new schizophrenomimetic drugs - Sernyl. Am. Med. Assoc. Arch. Neurol. Psychiat. 81:1959;363-369.
21. 2A sites for PCP induced locomotion in the rat. Eur. J. Neurosci. 11:1999;4419-4432.
22. Moghaddam B., Adams B.W. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science. 281:1998;1349-1352.
23. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1997;Academic Press, London.
24. Reid M.S., Hsu K., Berger S.P. Cocaine and amphetamine preferentially stimulate glutamate release in the limbic system: studies on the involvement of dopamine. Synapse. 27:1997;95-105.
25. Suzuki Y., Jodo E., Takeuchi S., Niwa S., Kayama Y. Acute administration of phencyclidine induces tonic activation of medial prefrontal cortex neurons in freely moving rats. Neuroscience. 114:2002;769-779.
26. Weinberger D.R., Berman K.F., Zec R.F. Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. Arch. Gen. Psychiat. 43:1986;114-124.
27. White I.M., Flory G.S., Hooper K.C., Speciale J., Banks D.A., Rebec G.V. Phcyclidine-induced increases in striatal neuron firing in behaving rats: reversal by haloperidol and clozapin. J. Neural Transm. 102:1995;99-112.
28. Winn P. Schizophrenia research moves to the prefrontal cortex. Trends Neurosci. 17:1994;265-268.
29. Yonezawa Y., Kuroki T., Kawahara T., Tashiro N., Uchimura H. Involvement of gamma-aminobutyric acid neurotransmission in phencyclidine-induced dopamine release in the medial prefrontal cortex. Eur. J. Pharmacol. 341:1998;45-56.